FTO and IGF2BP1 were identified as the predominant m6A genes in remodeling IME of AD, and SYNC and MAPK1IP1L were verified as the key genes in AD with a high m6A level context. The gene discussed is MAPK1IP1L; the disease is Alzheimer disease.